Defence Current Affairs
Defence Current Affairs of 2018-19 related to India’s Defence, Indian Armed Forces, Defence Production, Defence Acquisition and related matters for SSC, States Civils, UPSC and Other Competitive Examinations.
India and Pakistan have agreed to exercise restraint and work to defuse the situation on Line of Control (LoC) which has been witnessing repeated ceasefire violations.
This decision was taken at Indo-Pak Flag Meeting held at Chakan-da-Bagh LoC crossing point in Poonch sector of Jammu and Kashmir between the senior Army officers of the two countries.
In this meeting Indian side was represented by Brigadier H S Sareen while the Pakistani side was led by Brigadier Osman. Both nations also addressed a host of issues regarding ongoing ceasefire violations, sniping action and targeting of civilians on the LoC.
This is the first Flag Meeting between both countries held at the level of Brigadiers after nearly 20 days of heavy firing and shelling by Pakistani troops in Poonch district along the LoC.
Ceasefire Violations: Till September 2015, Pakistani troops have violated the ceasefire 25 times by shelling Indian civilian and military positions.
It should be noted that the last Brigade Commander level meeting between both neighbours was held in September 2014 after the LoC saw forty-five days of heavy firing by Pakistani troops since 1971.
Tags: Current Affairs 2016 • Defence • India-Pakistan • National
An indigenously developed second generation anti-tank guided missile, Amogha-I was successfully test fired.
Test: Test firing was carried out on September 10, 2015 at Babina Army Range, Madhya Pradesh. In the test two missiles were fired and both hit targets placed at 2.8 km as well as 2.6 km respectively. Both missile flights met all design parameters and designed path profile without any deviation.
About Amogha-I Missile
- Indigenously developed by state owned Bharat Dynamics Limited (BDL).
- It has maximum target range of 2.8 kms.
- The missiles will be inducted into Indian Army after due qualification and validation trials.